What HbA1c measures
HbA1c stands for glycated (“sugared”) haemoglobin. Haemoglobin is the red blood pigment that carries oxygen. When glucose circulates in the blood, some of it binds permanently to the haemoglobin. The higher the blood sugar over time, the greater the share of glycated haemoglobin.1
The value is given as a percentage of total haemoglobin (in Germany additionally in mmol/mol). Because red blood cells live about eight to twelve weeks, HbA1c reflects the average blood sugar of that period: hence the vivid name “blood-sugar memory”.1 The more recent weeks carry slightly more weight, because younger blood cells are more common.
The big practical advantage: for HbA1c you don’t need to be fasting, and it doesn’t swing from hour to hour like a single blood-sugar measurement.1 It smooths out the daily peaks and shows the trend.
The thresholds: normal, increased risk, diabetes
The diagnostic thresholds are largely uniform internationally. The American Diabetes Association (ADA), the World Health Organization (WHO) and the German Diabetes Society (DDG) use the same central threshold for diagnosis.23
The 6.5% threshold isn’t arbitrary: it’s based on large population studies in which the risk of diabetic retinal damage (retinopathy) rises markedly above this value.3 So it’s aligned with the risk of complications.
What your value means as average glucose
The percentage stays abstract if you deal with mg/dl or mmol/l every day. So HbA1c can be translated into an estimated average glucose (eAG). The basis is the ADAG study by Nathan and colleagues from 2008, which found a close linear relationship between HbA1c and actually measured average glucose in 507 people.4
Why the value matters: the research
HbA1c isn’t just a snapshot but a proven risk marker. The UK Prospective Diabetes Study (UKPDS 35), a large prospective study in type 2 diabetes, showed: each 1-percentage-point reduction in HbA1c was associated with a 37% lower risk of microvascular complications (eyes, kidneys, nerves), a 21% lower risk of diabetes-related deaths and a 14% lower risk of heart attack.5 Notably, there was no threshold, the lowest risk was at values in the normal range.5
In type 1 diabetes, the Diabetes Control and Complications Trial (DCCT) demonstrated the same relationship: more intensive blood-sugar lowering markedly reduced microvascular complications.6 Together these are two of the most important diabetes studies ever, and the reason HbA1c is central to monitoring today.
When HbA1c misleads
This is the most important and most often overlooked part. Because HbA1c depends on red blood cells, anything that changes their lifespan or number distorts the result: independent of the actual blood sugar.7
When red blood cells live longer, more glycated haemoglobin accumulates. The most significant case is iron-deficiency anaemia: a systematic review found elevated HbA1c values here that fell again after iron treatment, sometimes by more than a percentage point, without any change in blood sugar.7 Vitamin B12 or folate deficiency can also skew the value upward.79
If the lifespan of the blood cells shortens, there’s less time for glycation. HbA1c comes out too low. This affects haemolytic anaemias, acute or chronic blood loss, an enlarged spleen and the period after a blood transfusion.78 Advanced kidney disease can also distort the value.10
In pregnancy, HbA1c is not suitable for diagnosing gestational diabetes, an oral glucose tolerance test (OGTT) is used here.8 Haemoglobin variants (e.g. in certain inherited blood disorders) can lead to falsely high or low values depending on the lab method.7
Key takeaways
- HbA1c shows the average blood sugar of the last roughly 8–12 weeks.
- Thresholds: below 5.7% normal, 5.7–6.4% increased risk, from 6.5% the diabetes range – a second measurement confirms the diagnosis medically.
- The ADAG formula translates the value into a familiar average glucose (eAG).
- Per UKPDS, each percentage point lower markedly reduces the risk of complications – with no clear threshold.
- Anaemia, blood loss, pregnancy and haemoglobin variants can skew the value.
Article ID: SWF-W-013Please quote this ID for corrections or additions.
Sources
Sources as of: 21 Jul 2026.
- HbA1c: formation, glycated haemoglobin, ~8–12 week window; no fasting needed. Reference. mayocliniclabs.com (opens in a new window)
- Diagnostic HbA1c thresholds (ADA/WHO); ≥6.5% for diagnosis. Reference. emedicine.medscape.com (opens in a new window)
- 6.5% threshold aligned with retinopathy risk; DDG classification/diagnostics. ddg.info (opens in a new window)
- ADAG study (Nathan et al., 2008): linear HbA1c–average-glucose relationship (eAG). Diabetes Care. diabetesjournals.org (opens in a new window)
- UKPDS 35: each 1% lower HbA1c → 37% fewer microvascular complications, 14% fewer heart attacks; no threshold. BMJ/PubMed. pubmed.ncbi.nlm.nih.gov (opens in a new window)
- DCCT (type 1): intensive glucose lowering markedly reduces microvascular complications. PubMed. pubmed.ncbi.nlm.nih.gov (opens in a new window)
- HbA1c pitfalls: iron/B12/folate deficiency raise it; haemolysis, blood loss, variants lower/skew it. Systematic review. pmc.ncbi.nlm.nih.gov (opens in a new window)
- Haemoglobin variants and conditions that limit HbA1c reliability; pregnancy uses OGTT. Review. frontierspartnerships.org (opens in a new window)
- Radin M.S. (2014, and others): Limitations of haemoglobin A1c in the management of type 2 diabetes. Confounders: iron/B12/folate deficiency (falsely high), haemolysis/blood loss/splenomegaly (falsely low), haemoglobinopathies; iron repletion lowers HbA1c ~1.2%. PMC. pmc.ncbi.nlm.nih.gov/PMC7021345 (opens in a new window)
- Overview of confounders including pregnancy (OGTT instead of HbA1c), transfusion, kidney disease. Frontiers / British Journal of Biomedical Science (2024). frontierspartnerships.org (opens in a new window)